We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$2.48B
AUM Growth
+$396M
Cap. Flow
+$328M
Cap. Flow %
13.24%
Top 10 Hldgs %
85.69%
Holding
35
New
4
Increased
–
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
OSCR icon
Oscar Health
OSCR
+$752M
2
SANA icon
Sana Biotechnology
SANA
+$91.6M
3
CLOV icon
Clover Health Investments
CLOV
+$46.4M
4
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
+$25.7M

Top Sells

Rank Stock Value
1
LYFT icon
Lyft
LYFT
+$287M
2
TWLO icon
Twilio
TWLO
+$177M
3
LMND icon
Lemonade
LMND
+$83.6M
4
RCUS icon
Arcus Biosciences
RCUS
+$11.4M
5
RLAY icon
Relay Therapeutics
RLAY
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 61.01%
2 Technology 18.87%
3 Industrials 8.59%
4 Consumer Discretionary 5.24%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSCR icon
1
Oscar Health
OSCR
$9.41B
$646M 26.05%
+24,042,864
New +$752M
LYFT icon
2
Lyft
LYFT
$6.02B
$406M 16.35%
6,420,985
-5,149,539
-45% -$287M
DXCM icon
3
DexCom
DXCM
$31.5B
$290M 11.67%
3,222,724
– –
DM
4
DELISTED
Desktop Metal, Inc.
DM
$213M 8.59%
1,430,244
– –
RCUS icon
5
Arcus Biosciences
RCUS
$3.55B
$133M 5.35%
4,723,348
-326,438
-6% -$11.4M
ABNB icon
6
Airbnb
ABNB
$89.9B
$130M 5.24%
691,612
– –
UPST icon
7
Upstart Holdings
UPST
$2.63B
$107M 4.32%
832,423
– –
SANA icon
8
Sana Biotechnology
SANA
$871M
$94.1M 3.8%
+2,812,500
New +$91.6M
RLAY icon
9
Relay Therapeutics
RLAY
$4.1B
$54.2M 2.19%
1,568,486
-233,004
-13% -$10.1M
WORK
10
DELISTED
Slack Technologies, Inc.
WORK
$52.8M 2.13%
1,299,771
– –
BEAM icon
11
Beam Therapeutics
BEAM
$2.63B
$51.3M 2.07%
640,792
-22,899
-3% -$2.18M
KRON
12
DELISTED
Kronos Bio
KRON
$42.1M 1.7%
1,438,232
– –
DNTH icon
13
Dianthus Therapeutics
DNTH
$5.84B
$39.5M 1.59%
208,696
– –
CLOV icon
14
Clover Health Investments
CLOV
$2.2B
$31.1M 1.25%
+4,113,742
New +$46.4M
OPEN icon
15
Opendoor
OPEN
$3.64B
$26.5M 1.07%
1,292,697
– –
DBTX
16
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$18.6M 0.75%
+1,636,258
New +$25.7M
RAPT
17
DELISTED
RAPT Therapeutics
RAPT
$18.5M 0.74%
103,907
– –
IDYA icon
18
IDEAYA Biosciences
IDYA
$3.42B
$17.7M 0.71%
753,187
– –
LMND icon
19
Lemonade
LMND
$3.74B
$16.5M 0.67%
177,698
-647,045
-78% -$83.6M
SPRO icon
20
Spero Therapeutics
SPRO
$67.7M
$13.1M 0.53%
889,979
– –
TSHA icon
21
Taysha Gene Therapies
TSHA
$1.68B
$13M 0.52%
640,882
– –
SQZ
22
DELISTED
SQZ Biotechnologies Company
SQZ
$11.4M 0.46%
831,389
– –
EVLO
23
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$11.3M 0.46%
53,025
– –
FULC icon
24
Fulcrum Therapeutics
FULC
$273M
$7.99M 0.32%
678,141
– –
QNCX icon
25
Quince Therapeutics
QNCX
$22.9M
$6.81M 0.27%
946
– –
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q1 2021 Portfolio in Review

As of Q1 2021, Alphabet Inc held 35 positions worth $2.48B, up 19% from $2.08B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Alphabet Inc deployed $328M of net new capital in Q1 2021, opening 4 new positions. Its largest new stake was Oscar Health: 24,042,864 shares worth $646M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 36% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Lyft, an estimated $287M trimmed.

  • Alphabet Inc's largest Q1 2021 buy was Oscar Health: 24,042,864 shares worth $646M.
  • Alphabet Inc's biggest Q1 2021 reduction was Lyft, cutting an estimated $287M.
  • Alphabet Inc fully exited Aterian in Q1 2021, selling an estimated $10.1M.
  • Alphabet Inc's ten largest holdings make up 86% of its $2.48B portfolio in Q1 2021.
  • Alphabet Inc opened 4 new positions and closed 3 in Q1 2021.
  • Alphabet Inc's portfolio value rose 19% quarter-over-quarter to $2.48B.

Based on Alphabet Inc's 13F filing for Q1 2021, filed 15 Nov 2022.